Items where authors include "Peckham, D."

Jump to: Article | Conference or Workshop Item | Proceedings Paper

Number of items: 48.

Article

Reilly, C., Stavropoulos-Kalinoglou, A., Peckham, D. et al. (2 more authors) (2025) Physical Activity in Adults with Severe Asthma On-Treatment with Biological Therapies: A 1-Year Retrospective Analysis of Real-World Data. Pulmonary Therapy. ISSN 2364-1746

Whitaker, P., Gibson, A., Farrell, J. et al. (4 more authors) (2025) Prospective piperacillin lymphocyte transformation testing in patients with cystic fibrosis receiving regular and desensitization courses of piperacillin-tazobactam. The Journal of Allergy and Clinical Immunology: In Practice, 13 (3). pp. 594-609. ISSN 2213-2198

Tyrer, F., Gharibzadeh, S., Gillies, C. et al. (1306 more authors) (2025) Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study. Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics, 27 (2). pp. 767-776. ISSN 1462-8902

Clarke, E., Taylor, J., Watson, P. et al. (4 more authors) (2025) Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life. Pediatric Pulmonology, 60 (1). e27418. ISSN 8755-6863

Gharibzadeh, S., Routen, A., Razieh, C. et al. (1382 more authors) (2025) Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study. eClinicalMedicine, 79. 103005. ISSN 2589-5370

Topping, J., Lara-Reyna, S., Ibbotson, A. et al. (6 more authors) (2024) FACS-based detection of extracellular ASC specks from NLRP3 inflammasomes in inflammatory diseases. Clinical & Experimental Immunology, 219 (1). uxae117. ISSN 0009-9104

Spoletini, G., Webster, C., Burke, N. et al. (4 more authors) (2024) Isolation of Burkholderia cepacia complex in adults with Primary Ciliary Dyskinesia. ERJ Open Research. ISSN 2312-0541

Taquet, M., Skorniewska, Z., De Deyn, T. et al. (1085 more authors) (2024) Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK. The Lancet Psychiatry, 11 (9). P696-708. ISSN 2215-0366

Simmonds, N.J., Southern, K.W., De Wachter, E. et al. (26 more authors) (2024) ECFS standards of care on CFTR-related disorders: Identification and care of the disorders. Journal of Cystic Fibrosis, 23 (4). pp. 590-602. ISSN 1569-1993

Edwards, A.J., King, M.F., López-García, M. orcid.org/0000-0003-3833-8595 et al. (2 more authors) (2024) Assessing the effects of transient weather conditions on airborne transmission risk in naturally ventilated hospitals. Journal of Hospital Infection, 148. pp. 1-10. ISSN 0195-6701

Jarosz-Griffiths, H.H. orcid.org/0000-0001-5154-4815, Gillgrass, L., Caley, L.R. orcid.org/0000-0001-8957-1018 et al. (6 more authors) (2024) Anti-inflammatory effects of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis heterozygous for F508del. PLOS ONE, 19 (5). e0304555. ISSN 1932-6203

Lawson, C.A., Moss, A.J., Arnold, J.R. et al. (1341 more authors) (2024) Long COVID and cardiovascular disease: a prospective cohort study. Open Heart, 11 (1). e002662. ISSN 2053-3624

Burgel, P.-R., Ballmann, M., Drevinek, P. et al. (8 more authors) (2024) Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapy. BMJ Open Respiratory Research, 11 (1). e002049. ISSN 2052-4439

Sellers, Z.M., Assis, D.N., Paranjape, S.M. et al. (20 more authors) (2024) Cystic fibrosis screening, evaluation and management of hepatobiliary disease consensus recommendations. Hepatology, 79 (5). pp. 1220-1238. ISSN 0270-9139

Liew, F., Efstathiou, C. orcid.org/0000-0001-6125-8126, Fontanella, S. et al. (1457 more authors) (2024) Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease. Nature Immunology, 25 (4). pp. 607-621. ISSN 1529-2908

Edwards, A.J., King, M.-F., Noakes, C.J. et al. (2 more authors) (2024) The Wells–Riley model revisited: Randomness, heterogeneity, and transient behaviours. Risk Analysis: an international journal. ISSN 0272-4332

Calthorpe, R.J., Goodchild, N., Gleetus, V. et al. (10 more authors) (2024) A grumbling concern: A survey of gastrointestinal symptoms in cystic fibrosis in the modulator era. NIHR Open Research, 3. ISSN 2633-4402

Elneima, O., McAuley, H.J.C., Leavy, O.C. et al. (1398 more authors) (2024) Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study. International Journal of Epidemiology, 53 (1). dyad165. ISSN 0300-5771

Elneima, O. orcid.org/0000-0003-2480-8840, McAuley, H.J.C. orcid.org/0000-0001-8997-0764, Leavy, O.C. et al. (1398 more authors) (2024) Cohort profile: post-hospitalisation COVID-19 (PHOSP-COVID) study. International Journal of Epidemiology, 53 (1). dyad165. ISSN 0300-5771

Lord, J.M., Veenith, T., Sullivan, J. et al. (1020 more authors) (2024) Accelarated immune ageing is associated with COVID-19 disease severity. Immunity & Ageing, 21. 6. ISSN 1742-4933

Tachtatzis, P., Spoletini, G. orcid.org/0000-0002-5462-0083, Clifton, I. orcid.org/0000-0002-9758-9506 et al. (2 more authors) (2024) Changes in liver biochemistry and tacrolimus levels following the introduction of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and liver transplant. Journal of Cystic Fibrosis, 23 (1). pp. 99-102. ISSN 1569-1993

Taquet, M., Skorniewska, Z., Zetterberg, H. orcid.org/0000-0003-3930-4354 et al. (1262 more authors) (2023) Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury. Brain Communications, 6 (1). fcad357. ISSN 2632-1297

Brightling, C.E., Evans, R.A., Singapuri, A. et al. (1049 more authors) (2023) Long COVID research: an update from the PHOSP-COVID Scientific Summit. The Lancet Respiratory Medicine, 11 (11). e93-e94. ISSN 2213-2600

Raman, B., McCracken, C., Cassar, M.P. et al. (1038 more authors) (2023) Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study. The Lancet Respiratory Medicine, 11 (11). pp. 1003-1019. ISSN 2213-2600

Jackson, C., Stewart, I.D., Plekhanova, T. et al. (1082 more authors) (2023) Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study. The Lancet Respiratory Medicine, 11 (8). pp. 673-684. ISSN 2213-2600

Zheng, B., Vivaldi, G. orcid.org/0000-0003-0816-9276, Daines, L. orcid.org/0000-0003-0564-4000 et al. (1040 more authors) (2023) Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls. The Lancet Regional Health - Europe, 29. 100635. ISSN 2666-7762

Uluer, A.Z., MacGregor, G., Azevedo, P. et al. (103 more authors) (2023) Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials. The Lancet Respiratory Medicine, 11 (6). pp. 550-562. ISSN 2213-2600

Mainz, J.G., Zagoya, C., Polte, L. et al. (12 more authors) (2023) Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score. Frontiers in Pharmacology, 14. 1207356. ISSN 1663-9812

Calthorpe, R.J. orcid.org/0000-0003-3676-2712, Goodchild, N., Gleetus, V. et al. (10 more authors) (2023) A grumbling concern: an international survey of gastrointestinal symptoms in cystic fibrosis in the modulator era. NIHR Open Research, 3. 18. ISSN 2633-4402

Liew, F. orcid.org/0000-0002-8736-9198, Talwar, S., Cross, A. et al. (1439 more authors) (2023) SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination. eBioMedicine, 87. 104402. ISSN 2352-3964

Archangelidi, O., Cullinan, P., Simmonds, N.J. et al. (4 more authors) (2022) Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study. Journal of Cystic Fibrosis, 21 (2). pp. 302-308. ISSN 1569-1993

Sutharsan, S., McKone, E.F., Downey, D.G. et al. (51 more authors) (2022) Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial. The Lancet Respiratory Medicine, 10 (3). pp. 267-277. ISSN 2213-2600

Conference or Workshop Item

Calthorpe, R.J., Saumtally, H., Howells, L.M. et al. (13 more authors) (2024) P278 CF Tummy Tracker: ACF-specific patient reported outcome measure for daily gastrointestinal symptom burden. In: 47th European Cystic Fibrosis Conference, 05-08 Jun 2024, Glasgow, UK.

Shaw, N., Alldred, D. orcid.org/0000-0002-2525-4854, Anderson, A. et al. (4 more authors) (2024) P379 “Now I have a future”: adult perspectives and experiences of health status and adherence post CFTR modulator therapy. In: 47th European Cystic Fibrosis Conference, 05-08 Jun 2024, Glasgow, UK.

Shaw, N. orcid.org/0000-0003-3221-2588, Alldred, D., Anderson, A. et al. (4 more authors) (2023) Medication burden among adults with cystic fibrosis prescribed CFTR Modulators: a cross-sectional survey. In: 46th European Cystic Fibrosis Society Conference, 07-10 Jun 2023, Vienna.

Shaw, N. orcid.org/0000-0003-3221-2588, Alldred, D. orcid.org/0000-0002-2525-4854, Anderson, A. et al. (4 more authors) (2023) WS11.05 Medication burden among adults with cystic fibrosis prescribed CFTR Modulators: a cross-sectional survey. In: 46th European Cystic Fibrosis Conference, 07-10 Jun 2023, Vienna, Austria.

Proceedings Paper

Baxter, G., Pakzad, A., Rangelov, B. et al. (5 more authors) (2023) Quantitative computed tomography measures of disease severity in cystic fibrosis. In: ERJ Open Research. Adult Cystic Fibrosis Conference, 2023, 01-02 Dec 2023, Milan, Italy. European Respiratory Society .

Robson, E., Birring, S., Feltbower, R. orcid.org/0000-0002-1728-9408 et al. (2 more authors) (2023) Late Breaking Abstract - An exploratory study highlighting the use of night-time cough frequency as a potential marker of disease surveillance in patients with Primary ciliary dyskinesia and Cystic fibrosis. In: European Respiratory Journal. ERS International Congress 2023, 09-13 Sep 2023, Milan, Italy. European Respiratory Society , pa1108.

Webster, C., Farrell, E., Burke, N. et al. (2 more authors) (2023) A survey of patient engagement in primary ciliary dyskinesia. In: European Respiratory Journal. ERS International Congress 2023, 09-13 Sep 2023, Milan, Italy. European Respiratory Society , pa2712.

Adesina, A., Duff, A., Lee, T. et al. (5 more authors) (2023) 608 Staff evaluation of youth work in Leeds Cystic Fibrosis Service. In: British Paediatric Respiratory Society. RCPCH Conference, 23-25 May 2023, Glasgow, UK. BMJ Publishing Group , a215-a215.

Watson, R., Marner, B., Sum, C.K. et al. (2 more authors) (2023) Feasibility and effectiveness of a low-impact, virtual exercise programme for adults with cystic fibrosis. In: Journal of Cystic Fibrosis. 46th European Cystic Fibrosis Conference, 07-10 Jun 2023, Vienna, Austria. Elsevier , S196-S196.

Edwards, A.J., Noakes, C.J. orcid.org/0000-0003-3084-7467, López-García, M. et al. (2 more authors) (2023) A Mathematical Model for Assessing Transient Airborne Infection Risks in a Hospital. In: Proceedings of 17th International Conference on Indoor Air Quality and Climate (INDOOR AIR 2022). 17th International Conference on Indoor Air Quality and Climate (INDOOR AIR 2022), 12-16 Jun 2022, Kuopio, Finland. International Society of Indoor Air Quality and Climate (ISIAQ) , pp. 1222-1223. ISBN 9781713871811

Tachtatzis, P., Spoletini, G., Etherington, C. et al. (2 more authors) (2022) OP31 Can liver biopsy guide the management of deranged liver function tests in liver transplant recipients receiving Kaftrio? In: Gut. British Association for the Study of the Liver Annual Meeting, 20–23 September 2022, 20-23 Sep 2022, Leeds, United Kingdom. BMJ Publishing Group , A27-A28.

Shires, M. orcid.org/0000-0003-0904-6200, Marks, K., Peckham, D. orcid.org/0000-0001-7723-1868 et al. (1 more author) (2020) Sa1092 APICAL BK CHANNELS IN INTESTINAL EPITHELIA OF CYSTIC FIBROSIS (CF) PATIENTS: A POTENTIAL TARGET FOR STIMULATING POTASSIUMDRIVEN WATER SECRETION. In: Gastroenterology. Digestive Disease Week (DDW) 2020, 02-05 May 2020, Chicago, USA. Elsevier , S272-S273.

This list was generated on Wed Apr 2 20:02:53 2025 BST.